AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
Currently predicting for Fri, 24 May 2024

Trading levels for TXMD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.23 4.37 %
R2 2.19 2.44 %
R1 2.17 1.25 %
Current price: 2.14
Support S1 2.08 -2.61 %
S2 2.06 -3.81 %
S3 2.02 -5.74 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.54 18.69 %
R2 2.29 7.01 %
R1 2.15 0.467 %
Current price 2.14
Support S1 1.90 -11.21%
S2 1.89 -11.68%
S3 1.88 -12.15%

TXMD Predictions History

5 years ago
NameNotImportant predicted that TXMD for 2019-04-30 is going $4.35 (1.16%)

5 years ago
NameNotImportant predicted that TXMD for 2019-04-29 is going $4.20 (-1.87%)

5 years ago
NameNotImportant predicted that TXMD for 2019-04-24 is going $4.12 (0.49%)

5 years ago
PumpTheseNumbers predicted that TXMD for 2019-03-29 is going $5.02 (3.08%)

5 years ago
JS predicted that TXMD for 2019-03-29 is going $4.94 (1.44%)

5 years ago
Itzik.Kapon.103961 predicted that TXMD for 2019-03-29 is going $5.95 (21.43%)

Rank:

5 years ago
JS predicted that TXMD for 2019-03-05 is going $5.80 (0.17%)

6 years ago
JS predicted that TXMD for 2018-05-02 is going $5.81 (-1.36%)

6 years ago
JS predicted that TXMD for 2017-08-18 is going $6.15 (2.33%)

6 years ago
Victor..Li.8930 predicted that TXMD for 2017-08-18 is going $6.42 (6.82%)

Click to get the best stock tips daily for free!

About TherapeuticsMD Inc

TherapeuticsMD TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alon... TXMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT